Business

Results of Fundraising

Results of Fundraising.

articleMycelx Technologies Corp.February 28, 20195/company/mycelx-technologies-corporation/news/results-of-fundraising-2
Results of Fundraising

About this update from Mycelx Technologies Corp.

[{"type":"text","content":"\n \nRNS Number : 4975R MyCelx Technologies Corporation 28 February 2019  \n\nTHE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT (THE \"ANNOUNCEMENT\") VIA A REGULATORY INFORMATION SERVICE (\"RIS\"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \nTHIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.\n \nMYCELX Technologies Corporation\n(\"MYCELX\" or the \"Company\")\n \nResults of Fundraising\n \nMYCELX Technologies Corporation (MYX LN), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide traded on London Stock Exchange's AIM market, is pleased to announce the result of the Placing and Subscription announced earlier today.\n \nA total of 577,246 New Common Shares in the Company have been placed by Cantor Fitzgerald Europe at a price of 230 pence per share (the \"Issue Price\") raising gross proceeds of $1.75 million. Together with the proceeds of the Subscription for 26,387 New Common Shares at the Issue Price raising gross proceeds of $80,000, the Company has raised a total of $1.83 million to fund its expansion. \n \nThe Issue Price represents a discount of 6.1 per cent. to the Company's mid-market closing price as at 27 February 2019, being the last practicable date prior to the publication of the announcement of the Fundraising. \n \nAdmission and Total Voting Rights\n \nApplication has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM (\"Admission\"). It is expected that Admission will become effective at 08.00 a.m. on 13 March 2019. \n \nUpon Admission, the New Common Shares will trade in the Company's new restricted line of Common Shares under the ticker MYXR, and the New Common Shares, as represented by Depositary Interests, will be held in the CREST system and will be segregated into a separate trading system within CREST identified with the market \"REG S\" and ISIN USU624551151. The Company also maintains an unrestricted line of...

More updates from Mycelx Technologies Corp.